The chapter discusses concerns about Elon Musk's drug use and its impact on taxpayers, particularly in relation to his involvement with companies like Tesla and SpaceX. It highlights the reactions of board members and directors, as well as the story of a director who stepped down due to drug use.
Casey is taking his newsletter Platformer off Substack, as criticism over the company’s handling of pro-Nazi content grows. Then, The Wall Street Journal spoke with witnesses who said that Elon Musk had used LSD, cocaine, ecstasy and psychedelic mushrooms, worrying some directors and board members of his companies. And finally, how researchers found a new class of antibiotics with the help of an artificial intelligence algorithm used to win the board game Go.
Today’s guests:
- Kirsten Grind, enterprise reporter for The Wall Street Journal
- Felix Wong, postdoctoral fellow at M.I.T. and co-founder of Integrated Biosciences
Additional Reading:
We want to hear from you. Email us at hardfork@nytimes.com. Find “Hard Fork” on YouTube and TikTok.